These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 6866964)
1. [Intrabronchial administration of rifampicin in the complex treatment of patients with destructive pulmonary tuberculosis]. Pugachev VS; Shapovalov VP; Kovalenko NN Probl Tuberk; 1983 Apr; (4):25-7. PubMed ID: 6866964 [No Abstract] [Full Text] [Related]
2. [Effectiveness of intrabronchial administration of rifampicin in the treatment of patients with destructive pulmonary tuberculosis]. Syrovatka IuA Vrach Delo; 1985 Jan; (1):42-5. PubMed ID: 3984323 [No Abstract] [Full Text] [Related]
3. [Relation between the efficacy of complex therapy of patients with destructive pulmonary tuberculosis and the duration of rifampicin administration]. Sagalovich VIa; Manzhikova SR Probl Tuberk; 1984 Oct; (10):51-4. PubMed ID: 6514699 [No Abstract] [Full Text] [Related]
4. [Rifampicin and ethambutol treatment experience in chronic destructive pulmonary tuberculosis]. Petrova GN; Sedunova EA; Korotaeva TA Probl Tuberk; 1981 Mar; (3):73-4. PubMed ID: 7232397 [No Abstract] [Full Text] [Related]
5. [Experimental pharmacodynamic study of rifampicin administered by various methods]. Shapovalov VP; Mil'chenko KP; Kovalenko NN Antibiotiki; 1982 Jun; 27(6):434-7. PubMed ID: 7114830 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of pulmonary tuberculosis of native Black Africans a chemotherapeutic regime including rifampicin (apropos of 75 patients)]. Ayad M; Hane A; Kane PA Dakar Med; 1980; 25(1):65-74. PubMed ID: 7460740 [No Abstract] [Full Text] [Related]
7. [Treatment of newly diagnosed patients with infiltrative and disseminated pulmonary tuberculosis]. Ursov IG; Krasnov VA; B1tashova VA; Kudelia OA; Volkova ZhA; Gromyko NI; Borovinskaia TA Probl Tuberk; 1998; (4):21-2. PubMed ID: 9771031 [TBL] [Abstract][Full Text] [Related]
11. [Drug-resistant pulmonary tuberculosis at the penitentiaries]. Kononets AS Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326 [TBL] [Abstract][Full Text] [Related]
12. [Reparative processes during treatment of destructive pulmonary tuberculosis by maximum drug concentrations]. Bondarev IM; Zhigalina LI; Novoselova VP; Dolzhanskiĭ VM; Tsuprova AE Probl Tuberk; 1981 Feb; (2):61-4. PubMed ID: 7243757 [No Abstract] [Full Text] [Related]
13. [Chemotherapy with isoniazid and rifampicin for pulmonary tuberculosis]. Kawakami K Kekkaku; 2002 Aug; 77(8):569-71. PubMed ID: 12235849 [TBL] [Abstract][Full Text] [Related]
14. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]
15. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis]. Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883 [TBL] [Abstract][Full Text] [Related]
16. [Controlled trial of isoniazid.rifampicin.ethambutol regimen and isoniazid.rifampicin.pyrazinamide regimen in the primary chemotherapy for pulmonary tuberculosis (author's transl)]. Kekkaku; 1980 Jan; 55(1):7-13. PubMed ID: 6988627 [No Abstract] [Full Text] [Related]
17. [A five year follow-up study of antituberculosis chemotherapy with and without rifampicin (author's transl)]. Matsumiya T; Yoshida F; Inoue M; Yoshimura M; Ogawa T; Yoshida R; Ishii A Kekkaku; 1980 Feb; 55(2):43-51. PubMed ID: 7373965 [No Abstract] [Full Text] [Related]